Breastfeeding plays an essential role in the healthy development of a newborn, but human milk is obviously compromised by pollutants from our environment. The main contaminants of human milk with endocrine-disrupting compound (EDCs) have raised concern for public and environmental health. Bisphenol A (BPA), which can leach from plastics, are among the most well-studied. Since EDs are known to cross the mammary gland barrier and BPA may accumulate in the neonate, "BPA-free" products have been introduced to the market. However, recent studies have shown that alternative bisphenols (e.g. BPS, BPF) can be detected in breast milk, have ED activities and may have developmental effects similar to BPA.
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Introduction
Accumulating research shows that environmental stressors during gestation, infancy, and early childhood are risk factors for diseases in adulthood. Endocrine disrupting chemicals (EDCs) are a class of stressor that could affect the normal growth and development process and increase the risk of disease across the lifespan by altering the homeostasis or action of endogenous hormones of the endocrine system [1, 2] . Humans may encounter EDCs daily and during all stages of life, from conception and fetal development to adulthood and senescence. Nevertheless, prenatal and early postnatal windows are the most critical for proper development. The fetus, infant, and child may have higher exposure to some EDCs than adults because of developmentally-appropriate differences in diet, behaviour, physiology, anatomy, and toxicokinetics [3] .
Among representative EDCs are Bisphenol A (BPA) [4] and its analogues (BPS, BPF) which have shown similar endocrine-disrupting effects to BPA [5] . Infants and children were exposed to Bisphenols (BPs) through several routes, including gestational and lactational transfer, inhalation and ingestion of contaminated dust, dermal exposure, and oral exposures through food and beverage containers/films [6] [7] [8] . However, the transplacental and lactational exposure as the most relevant exposure for fetus and neonates, respectively, is considered.
This review aims to summarize some of developmental "toxicity" due to exposure to EDCs during pregnancy and lactation taking as an example widely-used BPs. The developmental effects of very low doses of BPs are underlined, with emphasis on favourable breastfeeding as a route of the exposure, with several unique features.
Susceptibility to EDCs during early development
Although the majority of the human population is exposed to EDCs, particular concern has arisen regarding the potential effects of exposure to EDCs during early development. There are three principal reasons why the impact of EDCs may be more apparent on the developing fetus and the postnatal offspring. Firstly, many of the normal homeostatic endocrine feedback mechanisms and the detoxification ability are not fully developed, and many low dose exposures have more adverse effects on the developing fetus than adult ones [9] . Secondly, it appears that one of the characteristics of the EDCs is that the binding affinity of these compounds to sex hormone binding globulin is low. Hence, the metabolism of these compounds in the fetus maybe particularly low [10] . Thirdly, while the mother may have been exposed to these compounds at low exposure levels during life, these compounds tend to be highly lipophilic, and some of them are accumulated in fat stores in the body [11] . These stores maybe rapidly mobilized during the energetically-expensive periods of pregnancy, and in particular lactation, and they exert endocrine disrupting effects in late pregnancy and post-natal life [12] . Hence, the underdeveloped organism maybe exposed to unusually high concentrations of compounds that cannot be easily metabolized or excreted at these stages of development. Moreover, breast milk represents exclusive food for a nursed child and, therefore, this specific route of exposure of neonates seems to be genuinely dangerous for further development of the body.
Two points of view on breastfeeding in the age of plastics
Most environmental pollutants are omnipresent and detected even in oceans, glaciers and rocks. The recent age can be called the "age of plastics" and, therefore, mankind is exposed widely and systematically every day, in particular, through daily needs items. Human milk nowadays has been unintentionally compromised by pollutants from our environment, as a result of living in a 'modern' industrialized world [13] . The focus of attention on environmental chemicals in human milk can obscure the fact that human milk confers numerous and well-documented health benefits to a nursing infant. When considering the potential risks associated with environmental chemicals in human milk, it is equally important to consider the benefits associated with breast-feeding. In this way, a balanced picture of the advantages and disadvantages of breastfeeding will be mentioned in the following section.
Human milk is a biological fluid synthesized in the mammary tissue by cellular mechanisms delicately designed to provide the infant with the precise quantitative and qualitative growth-and immune-enhancing factors, while at the same time enhancing mother-child bonding. Because human milk provides a superior nutrition source for an infant, breast-feeding remains the preferred choice for infant nutrition. In fact, human milk contains nutritive (e.g. lipids, carbohydrates, proteins, amino acids, minerals, and vitamins) and non-nutritive (e.g. enzymes, immunoglobulins, nucleic acids, hormones, growth factors, and cells, including macrophages, lymphocytes, and epithelial cells) constituents that both contribute to the infant's well-being [14] . The American Academy of Pediatrics (AAP) "recommends breast milk as the preferred source of feeding for almost all babies for at least the first year of life" because "breast-feeding provides health, nutritional, immunologic, developmental, psychological, social, economic and environmental advantages unmatched by other feeding options", and "epidemiologic research shows that human milk and breast-feeding provide advantages with regard to general health, growth, and development, while significantly decreasing risk for a large number of acute and chronic diseases" [15] . Therefore, it is obvious that maternal benefits include more rapid postpartum recovery, increased child spacing, decreased risk of osteoporosis, lower incidence of both breast cancer and ovarian cancer, an earlier return to pre-pregnancy weight, and emotional benefits such as empowerment and mother-infant bonding [16] .
On the other hand, breastmilk represents a vehicle for many compounds which the mother eats and/or is exposed to. Since the 1800s, maternal milk has been known to contain chemical contaminants that could adversely affect nursing infants, and potentially hazardous persistent environmental chemicals were first detected in the 1950s [17] . Thus, breastfeeding, in addition to its beneficial properties, can potentially cause high-dose exposure of chemical pollutants to neonates, which can be more susceptible to adverse effects resulting from chemical exposures than adults due to the rapid mental and physical changes that take place during the prenatal and neonatal periods [3, 18] . Most of the research on environmental chemicals in human milk has concentrated on a group of chemicals referred to as persistent, bioaccumulative, and toxic (PBT) [14] . There are both practical and health-related reasons for concentrating on PBT chemicals. One practical reason is that these chemicals tend to be lipophilic ("fat-loving") and persistent. The PBTs include parabens, octylphenols, BPs, dioxins, furans, dichlorophenylcloroethane (DDT), organochlorine cyclodienes, semi-volatile organohalogens, heavy metals, pesticides, volatile and other organic compounds [19] .
Lactational transfer of toxic chemicals into breast milk
Some indication of the potential excretion of chemicals into breast milk may be obtained by considering the theoretical aspects of drug transfer [20] . The alveolar cells of the mammary glands are the interface between maternal blood and milk, and substrates for milk production and xenobiotics are brought to the alveoli by the bloodstream. About 3 to 4 percent of milk consists of lipids; therefore, transfer of lipid-soluble non-ionized chemicals by passive diffusion through the membrane is favoured. The lipid soluble chemicals diffuse along with fats from plasma into the mammary gland and are excreted with milk during lactation. Several other mechanisms including exocytosis (for water-soluble components), the carrier mediated transport system and active transport (for small ions and molecules), and pinocytosis and paracellular movement [20, 21] have also been implicated.
The overall rate and extent of accumulation of chemicals in the milk compartment and subsequent exposure is controlled by maternal factors, infant factors, and chemical physiochemical properties. Maternal endogenous factors include age, general physiological status, uncommon auto-immune properties, thyroid disorder and dietary habits, history of smoking in the year before pregnancy, consumption of alcohol during the first trimester of pregnancy, number of pregnancies, history of previous deliveries and lactation, duration of lactation and the number of children being breastfed at one time [22, 23] . Infant factors affecting exposure include the suckling pattern (the volume of milk consumed, frequency, and timing relative to maternal plasma concentrations) and xenobiotics oral bioavailability in the neonate [24] . Chemicals physiochemical properties are determined by factors such as ionization, plasma protein binding, molecular weight, drug lipophilicity and its pharmacokinetics in the mother [25] . Global environmental conditions (temperature, pressure) and individual exposure conditions (degree and duration of maternal exposure, presence and levels of xenobiotic) may also alter uptake, distribution, biotransformation, and excretion of the toxic chemical [26] . Furthermore, milk composition changes over time (colostrum, transitional milk and mature milk) and during a single suckling (foremilk, hindmilk). The first postpartum week colostrum has a high protein (10%) and a low fat (1%) content; however, mature milk has a low protein (1%) and a high fat (4%) level. Because of the high protein content in colostrum, chemicals with high protein binding may be more likely to pass into human milk at this time [14] .
Occurrence of EDCs in milk and toxicokinetics
Due to its fat content, both breast and dietary milk could be polluted by many xenobiotics characterized by lipophilic properties [27, 28] . Breast milk, milk from lactating cows and dairy products are widely consumed by infants, and many adults throughout the world, and the occurrence of quantifiable amounts of EDCs has raised concern for public and environmental health [29] . BPA is considered an endocrine-disrupting chemical that has the efficacy of the hormone estradiol in some tissues and antagonizes thyroid hormone action in addition to its antagonizing androgenic action [4] . BPA is found in dentistry composites, paints, plastics, and toys and is used to cover food and beverage cans, polycarbonate beverage bottles and, not long ago, baby bottles and infant formula packaging. In 2010, the World Health Organization [30] estimated that breastfed infants between the ages of 0-6 months were exposed to 0.3μg/kg body weight (BW) BPA daily, and BPA levels in infants fed a formula from polycarbonate bottles were estimated at eight times breast-fed concentrations, and those given a canned formula in polycarbonate-free bottles were exposed to 0.5μg/kg BW [30] .
Following oral administration in live animals and humans, BPA is completely and rapidly absorbed from the gastrointestinal tract. Hepatic clearance of BPA to its glucuronidated metabolite (BPA-Glu) is rapid and complete, and BPA-Glu is the predominant substance found in plasma. Urinary excretion is the only way to eliminate BPA-Glu. Adult human studies have reported that BPA has a very short half-life and conjugate forms of BPA are excreted into urine with a half-life of <6 h [31] . However, in the case of the specific populations, such as developing fetuses, growing infants, and young children, whose chemical metabolizing systems (glucuronidation activity) are underdeveloped, even moderate exposure can lead to higher internal concentration of BPA [32, 33] . In recent years, use of physiologically based pharmacokinetic (PBPK) modelling has been quite popular in human health risk assessment [34, 35] . Most publications addressed PBPK modelling of BPA adult exposure [33, 36] . Few studies have addressed BPA pharmacokinetic during the gestation [35] and lactation period [32, 37] . During breastfeeding, the absorbed portion of BPA is quickly transferred into the breast by passive diffusion, resulting in the observed high concentration of BPA in the human milk quickly (hours) after BPA consumption [23] . This is due to the high lipophilicity of this chemical (octanol-water coefficient K ow : 2.2-3.4), which incorporates into human milk at levels comparable to the concentrations in fatty tissues in the body [38] . Many studies reported the occurrence of different levels of BPA in colostrum and human milk. BPA is present in human milk in an unconjugated or conjugated form [39] . However, conjugated BPA does not display any estrogenic activity [38] ; consequently, the measurement of unconjugated-BPA (u-BPA) is more suitable in the risk assessment of BPA in breastfeeding infants. BPA in mature milk reflects the recent exposure of the mother. This is different from BPA content in colostrum, which reflects accumulated mother exposure during the second half of the pregnancy [38] . In addition to contamination of breast milk by BPA, several studies suggest that BPA, even at low doses, can affect mammary gland development [40, 41] and leads to the development of breast cancer during adulthood [42] [43] [44] . Furthermore, rats exposed to BPA in the womb presented abnormalities in adult mammary tissue and alterations in the milk protein content by the time they were feedings their pups [45] . Considering that BPA is an EDC, after birth, BPA exposure alters sensitivity to estradiol-dependent mammary gland development and progesterone-dependent mammary cell proliferation [46] . Estrogenic and anti-androgenic potencies of BPs other than BPA (BPA analogues) have been the subject of recent intense investigations. Several studies showed that BPS, BPF and BPAF exert estrogenic effects and partly exert anti-androgenic and thyroid-disrupting effects with potencies similar to or higher than those of BPA [5, 47] . The metabolism and distribution of BPA analogues in humans have not been as well studied as in case of BPA; nevertheless, some experiments suggest that BPF and BPS metabolism is similar to BPA metabolism [5] . Moreover, to our best knowledge, only few studies [48] [49] [50] [51] are focused on bisphenol analogues in breast milk.
Developmental effect of BPs Effect on growth and development
Several emerging concerns pertaining to BPs exposure during early development have the potential for these EDCs to contribute to changes in body weight. Many studies performed with rodents have demonstrated increases in body weight of the male and female offspring issued from mother rodent exposed to a low dose of BPA during gestation and or lactation periods [52] . There are few toxicological data on BPA analogues from in vivo experiments on physiological functions like energetic metabolism. The study of Ivry del Moral et al. [53] demonstrated for the first time that perinatal exposure to low doses of BPS induced a significant overweight in male mice. BPA may exert obesogenic effects through various pathways, including via its activity as an estrogen and glucocorticoid receptor agonist, as well as by interference with thyroid hormone pathways and by activation of peroxisome proliferator-activated receptor-γ (PPARγ) [54] . In-depth characterizations of growth and development following BPA analogues exposure have been also conducted, with many consequences discussed below.
Effect on nervous system development and behaviour
BPs exposure affects the nervous system physiology at all life stages. Vulnerability is higher in the developing brain due to the lipophilic chemical structure that allows it to easily cross the blood-placental and blood-brain barriers, as well as to be delivered to offspring through lactation [55] . Emerging research on maternal EDCs exposure and child neurodevelopmental outcomes have recently found significant associations between prenatal and postnatal BPA exposure and long-term alterations in offspring behaviour, mainly including three behavioural categories: anxiety and exploration, learning and memory, and socio-sexual behaviours across mammalian species [56, 57] . In addition, several studies in rodents confirmed that exposure during gestation and lactation period to a low, but environmentally relevant BPA dose, produced subtle alterations in maternal behaviour, including reduction of subsequent maternal nursing behaviour and an increase in time spent away from the nest over the first two weeks post-partum. Early life BPA exposure may also decrease the female offspring engagement in maternal cares in mice and rats [58] , indicating the transgeneration-al impact of BPA exposure on the neuroendocrine substrates modulating maternal behaviour. Several studies have suggested that BPA analogue might be also toxic to the nervous system and affect animal behaviour. BPS exposure was found to alter behaviour in terms of increased anxiety and reduced interest in social interactions in rats [59, 60] . Recently, BPS and BPF were also found to affect dopamine (DA) -and serotonin (5-HT)-related genes, and the neuro-steroidogenesis-related enzyme, 5α-reductase (5α-R), in the prefrontal cortex of juvenile female rats due to maternal exposure [61] .
Effect on male and female reproductive system development
Experimental studies on the effects of BPs on the reproduction of male rodents have revealed an adverse influence on the development of the testes and on the spermatogenesis of adult individuals following prenatal in utero or early postnatal exposure. Exposure to BPA during the period of development of the testes is frequently linked to a range of negative effects in adult testes, e.g. decreased levels of testicular testosterone, decreased weights of the epididymis and seminal vesicles, a decrease in daily sperm production per gram testis, and increased weights of the prostate and preputial [62] . Recent animal studies reported that both prenatal and postnatal exposure to low-dose BPA decreased sperm numbers and alter early male sexual development [63, 64] . Additionally, induction of testicular oxidative stress or apoptosis was observed in mice and rats exposed to low-dose BPA during the prenatal or postnatal periods [65] . Few studies have indicated that low-dose BPA exposure potentially altered the epigenetic pattern in the testes, including increased rates of methylation of Insulin like growth factor-2 (IGF2) and decreased protein lysine acetylation levels in rats [66, 67] . Overall, the strength regarding current evidence for risk assessment regarding low dose BPA exposure is still limited. Concerning the female reproductive system, experimental studies in rodents have indicated that prenatal and postnatal exposure to low dose BPA resulted in decreased ovarian weights, follicle numbers, and primordial follicle recruitment in Wistar rats, as well as increasing the number of corpora lutea and causing a delay in vaginal opening [68, 69] . Additionally, Calhoun et al. reported that early life exposure to BPA via food consumption altered three genes (Hoxa13, Wnt4 and Wnt5a) involved in reproductive organ development in rhesus macaque uterus [70] . A study regarding BPA exposure on the ovaries of F1 generation mice resulted in a non-monotonic dose-relationship with several transgenerational effects found in the F3 generation [71] .
Regarding BPA analogues, only few studies have examined the effects of these BPs on female and the male reproductive systems. BPS elicits reproductive and germline toxicity in Caenorhabditis elegans [72] . This reproductive influence was also seen in some mice experiments. Recent studies have reported that prenatal and postnatal exposure to BPA analogues disrupts adult reproductive functions in male and female mice [73] [74] [75] . Specifically, BPE and BPS in addition to BPA impair estrous cyclicity, follicle counts, steroidogenesis, and fertility in female mice [75] . More importantly, the results of these recent studies suggest that prenatal exposure to BPA analogues (BPE and BPS) transgenerationally affects female reproductive functions [76] . These results support recent reports that BPS affects female puberty onset and estrous cyclicity in rats [77] , mouse and porcine oocytes [78, 79] and estradiol-17β production in bovine granulosa cells [80] . Concerning the male reproductive system, the same authors have found that postnatal exposure to BPE and BPS impairs spermatogenic output and motility, and induces alterations of the spermatogenesis [74] .
Conclusion and Perspectives
Breastfeeding potentially causes high-dose exposure of chemical pollutants including EDCs. The levels of environmental chemicals are influenced by global and local use patterns of chemicals, and furthermore by diet, maternal age, parity and duration of lactation. The benefits of breastfeeding outweigh any potential risk associated with this practice, but close surveillance is needed to keep it as contaminant free as possible. Although BPA is being replaced by its analogues (BPS and BPF), recent reported detections of BPA analogues in human milk associated with some developmental effect, create a compelling reason to increase research on the health effects of these chemicals during early life. Moreover, increase monitoring efforts (breast milk analyses), toxicokinetics (the appropriate breastfeeding PBTK models are still lacking), and design experimental work describing molecular action are needed for the elimination of deleterious effects. Taken together, this review appeal to the other side of the breastfeeding: in addition to its beneficial effect, the negative effect of endocrine disruptors on infant health should be considered. Moreover, in the light of endocrine disruptors, breast milk donation and/or sharing programme should be subjected to a control and avoid milk contaminated with pollutants.
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